Skip Navigation

Human Reproduction 2005 20(4):1112; doi:10.1093/humrep/deh658
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Reich, O.
Right arrow Articles by Regauer, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reich, O.
Right arrow Articles by Regauer, S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved.

Do drugs that stimulate ovulation increase the risk for endometrial stromal sarcoma?

Olaf Reich1,3 and Sigrid Regauer2

Departments of 1 Obstetrics and Gynecology and 2 Institute of Pathology, Medical University of Graz, Austria

3 To whom correspondence should be addressed. Email: olaf.reich@meduni-graz.at

The first 10% of the full text of this article appears below.

Sir,

We read with interest the epidemiological study by Brinton et al. (2004)Go, which reports a statistically significant risk for invasive . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?